baber/WOPTO huggingface dataset:
Patent JP-2001500071-A (JP)
Title: 液晶ディスプレイ装置の製造方法
IPC: G02F1/13357
Filed: 1997-02-18
Abstract: (57)【要約】
光学要素（２０）を光学装置内に埋め込むための方法及び装置が示されている。上記方法においては、樹脂層（３０）に複製表面形状を形成し、上記複製表面形状を有する光学要素層から樹脂層を切断し、上記複製表面形状を１つの層によって被覆し、基体屈折率を有する基体（６０）を作り、及び上記基体屈折率に本質的に等しい調和屈折率を有する基体に上記層を接続する。この方法及び装置によれば、全体のコストを高めることなく表面形状を複製できる。
Patent JP-2000516107-A (JP)
IPC: A61B17/32
Filed: 1996-05-16
Abstract: The present invention relates to a balloon trocar (15) to be inserted through a small incision in the body for dissecting, separating or retracting body tissue. Said ballon trocar comprises a balloon housing portion (18) which is connected to a trocar portion (17) at a first end thereof and which accomodates a balloon (16) which is sealingly connected to the proximal end of the balloon housing and to the trocar portion (17) at its second distal end. The balloon extends from said second distal end back through the trocar to the proximal balloon housing portion (18), wherein the balloon trocar (15) is fitted with an inflation port (21) so as to be able to inject an inflation medium into the ballon trocar (15) to inflate the balloon (16) such that the balloon is forced to evert out through the trocar portion (17). <IMAGE>
Patent JP-2001521395-A (JP)
IPC: C07K16/00
Filed: 1998-04-23
Abstract: The present invention relates to methods for identifying nucleic acid molecules encoding (poly)peptides that interact with target molecules. The method of the present invention is particularly characterized by an in vitro translation step under conditions that allow formation of polysomes in the presence of antisense oligonucleotides complementary to the tag-coding sequence of ssrA-RNA. The present invention further relates to kits that are useful for carrying out the method of the invention.
Patent JP-2000512038-A (JP)
IPC: G09F7/22
Filed: 1998-03-20
Abstract: A portable sign stand (10, 80) with rollers (100) and an adjustable weighted base (12, 82). The base member (12, 82) has one or more compartments (22) so that liquid or solid ballast can be added to stabilise the sign stand (10, 80) in windy conditions. Wheels (32, 100) are provided on one edge of the base member (12, 82) in order to allow the sign stand (10, 80) to be rolled and easily moved to different positions. The axle member (34, 98) for the wheels (32, 100) is held in place on the base member (12, 82) by a bracket member (42, 94) which also helps secure the sign member (14, 84) to the base member (12, 82). A pair of springs (20, 106), resilient members or the like can be used to connect the sign member (14, 84) to the base (12, 82) in order to provide a better wind-resistant sign stand (10, 80). <IMAGE>
Patent JP-2001522244-A (JP)
IPC: A01K67/027
Filed: 1998-04-20
Abstract: This invention provides methods for obtaining targeted gene modification in vertebrate cells using parvoviral vectors, including adeno-associated virus (AAV). The parvoviral vectors used in the methods of the invention are capable of targeting a specific genetic modification to a preselected target locus in a cellular genome by homologous pairing.
Patent JP-2002500787-A (JP)
Title: ネットワーク・システムにおけるデータボリュームの分散ミラーリング
IPC: G06F11/14
Filed: 1998-04-28
Abstract: (57)【要約】
ネットワーク上のワークステーション（１３，１５，１７）から１つ以上のファイル・サーバ（１９）へ作業プロダクトをバックアップし、１つ以上のファイル・サーバ（１９）からワークステーション（１３，１５，１７）への作業環境のマスターコピーの変更の更新を実行するネットワーク（９）のミラーリング・システム（１４）。ある実施例において、ミラーリング・システム（１４）は、ネットワークのトラフィック・レベルをチェックし、トラフィック・レベルが所定値以下の場合に、データ転送を開始する。バックアップ及び更新が行われ、状態リスト（２９）が維持され、ネットワーク上の各ワークステーション（１３，１５，１７）のバックアップ及び更新の改訂レベルが追跡される。ある実施例においては、バックアップ又は更新し損なったワークステーション（１３，１５，１７）がリストされ報告される。
Patent JP-2001525126-A (JP)
Title: セラミック基板を備えた電力用半導体モジュール
IPC: H01L25/18
Filed: 1998-05-07
Abstract: (57)【要約】
接続素子が、プラスチックハウジングに設けられた開口に圧入されている電力用半導体モジュールが提供される。このような手段により、基板と接続素子との間の内部ボンディング結合の信頼性が改善される。なぜならば、接続素子がプラスチックハウジング内で緩んでしまう危険がもはや生じないからである。
Patent MD-20030233-A (MD)
Title: Bicycle with rotary motion amplifiers
Inventor: FIODOROV NICOLAI
IPC: B62M1/36
Filed: 2003-09-18
Abstract: The invention relates to the bicycle engineering.The amplifier of the bicycle front wheel rotary motion comprises two pairs of magnetic plates in the form of rings, installed onto the wheel spokes and onto the fork feathers, the adjacent surfaces of each pair of rings having the same polarity.The pedals of the bicycle are joined between them with a cable by a system of running pulley and fixed pulleys.
Patent MD-20060071-A (MD)
Title: Device for vertebral column cervical part traction
Inventor: MINISCURTA BORIS
IPC: A61F5/04
Filed: 2006-02-27
Abstract: The invention refers to medicine, namely to orthopedics and traumatology, and may be used for traction of vertebral column cervical part. The device for vertebral column cervical part traction comprises two rods and a head holder in the form of cranial cuff (6) made in the form of ring with screws (11) for cranium fixation. each rod is made compound of two parts: its upper part is made in the form of screw (1) ending in a head (2) with a hole, and the lower one comprises two rests (3), one ends of which are rigidly fixed at an angle with each other to a bush (5), installed with the possibility of free displacement over the screw (1) of the upper part of the rod, and the opposite ones to a shoulder holder (4). The cranial cuff (6) is equipped with two diametrically opposite to and rigidly fixed onto the outside of the cuff studs (7), conjugate to the holes in the heads of the screws.
Patent MX-148024-A (MX)
Inventor: WILSON JOHN EDWARD
IPC: A01F7/06
Filed: 1979-04-27
Abstract: The rotor of an axial flow rotary separator carries a series of circumferentially spaced threshing bars which move in a threshing relationship with a cylindrical threshing grate as the rotor rotates and are characterized in having upstream and downstream portions, respectively providing greater and lesser grate clearances, the greater clearance of the upstream portion facilitating the entry of material into the threshing section of the separator.
Patent NZ-190446-A (NZ)
Title: Sealing anodic oxide films on aluminium
Inventor: CARTER B G
IPC: C25D11/24
Filed: 1979-05-14
Abstract: A process for sealing anodic oxide films on aluminium comprises immersing the anodised aluminium in a bath containing an aqueous solution of a sealing accelerator, preferably triethanolamine, at a pH of 7 to 11, followed by conventional treatment in a hot water bath containing an anti-smut additive. The preliminary accelerator treatment allows the sealing step to be substantially accelerated and permits the production of an essentially smut-free surface on the sealed anodic oxide film.
Patent NZ-219998-A (NZ)
Title: Lysostaphin and its production by genetic engineering methods
Inventor: RECSEI PAUL A
IPC: C12N9/52
Filed: 1987-04-15
Abstract: The present invention provides recombinant plasmids which is transformant microbial hosts express lysostaphin, a bacteriocin that kills most known staphylococcal species. The invention also provides lysostaphin, substantially free from non-lysostaphin contaminants. Recombinant plasmids, pRG5, pJP1, pDF8 and pRP1, were derived by inserting a 1.5 kilobase segment of DNA coding for lysostaphin into the cloning vectors, pUC8, pBC16, pBD64 and pSPV1, respectively. E. coli strain JM105 transformed by pRG5 and members of Bacillus species, including B. subtilis and B. sphaericus transformed by pJP1, pDF8 and pRP1 produce lysostaphin which is immunologically and electrophoretically indistinguishable from that produced by S. simulans, the natural source. Furthermore, B. sphaericus strain 00/pJP1 transformants produce five times the amount of lysostaphin as S. simulans. The invention also provides the 1.5 kbp DNA fragment coding for lysostaphin. The sequence of the DNA encodes preprolysostaphin, a monomeric 389 amino acid protein, which is posttranslationally processed to mature lysostaphin.
Patent NZ-225940-A (NZ)
Title: Interleukin-1 inhibitors (il-1 inh) and pharmaceutical compositions
Inventor: DAYER JEAN-MICHEL
IPC: C07K14/00
Filed: 1988-08-26
Abstract: This invention relates to interleukin 1 inhibitors (IL-1 INHs) that selectively inhibit interleukin 1 activity. The invention also relates to processes for purifying such IL-1 INHs from urine and for producing such IL-1 INHs by hosts transformed with recombinant DNA molecules comprising DNA sequences encoding the inhibitors, and to methods of treatment and compositions characterized by such IL-1 INHs. These methods and agents are useful in immunosuppressive and anti-inflammatory applications and therapies.
Patent NZ-226786-A (NZ)
Title: Thermoplastic polymer mixtures comprising two different acrylonitrile and vinyl aromatic monomer-grafted rubbers and a thermoplastic polymer having polar groups
Inventor: VROOMANS HUBERTUS JOHANNES
IPC: C08L57/00
Filed: 1988-10-31
Abstract: Thermoplastic polymer mixture on the basis of a vinylaromatic compound and acrylonitrile on a rubber and a thermoplastic polymer with polar groups, characterized in that the polymer mixture consists of:   a) 5-90 wt.% of a graft copolymer of a vinylaromatic compound and acrylonitrile on a rubber;   b) 5-90 wt.% of a thermoplastic polymer with polar groups; c) 1-90 wt.% of a graft copolymer of a copolymer of a vinylaromatic compound and acrylonitrile on a diene rubber, on the rubber moreover being present monomers of a vinylaromatic compound and of a carboxy- and/or imide-containing compound in a molar ratio from 5:1 to 1:5.   The polymer mixture shows an optimum balance of properties with respect to notch impact strength and heat deflection temperature. The polymer mixture is very easy to synthesize with the aid of a mixing device.
Patent NZ-228442-A (NZ)
Title: Method for the selection of large dna sections
Inventor: WOHLLEBEN WOLFGANG
IPC: C12N15/10
Filed: 1989-03-21
Abstract: DNA segments from mutants can be obtained very straightforwardly by isolating from the strain to be mutated the total DNA, cleaving the latter into small fragments and integrating into a temperature- sensitive plasmid with another selection marker which is selectable in E. coli, transforming the hybrid plasmid population obtained in this way into the starting strain, selecting the transformants by selection for the marker, eliminating the hybrid plasmids by raising the temperature above the threshold of the temperature-sensitive plasmid, and selecting the mutants by renewed selection for the marker. Construction of a cosmid gene bank with the DNA of these mutants results, by selection for the marker which has been introduced and is selectable in E. coli and for the cosmid-intrinsic marker, directly in cosmids which contain the mutated gene.
Patent NZ-232072-A (NZ)
Title: Leukaemia inhibitory factor from livestock and its use in enhancing development of mammalian embryos
Inventor: GOUGH NICHOLAS MARTIN
IPC: C12N5/073
Filed: 1990-01-10
Abstract: Disclosed is the in vitro development of mammalian embryos to the implantation stage by culturing the embryos in a medium containing leukemia inhibitory factor (LIF).
Patent NZ-233291-A (NZ)
Title: Deactivating or deodorising a solution containing an organophosphorus biocide using activated carbon
Inventor: COOPER KENNETH GRAHAM
IPC: A01N57/34
Filed: 1990-04-11
Abstract: Solutions of organophosphorus biocides which also contain dissolved oxygen are deactivated by adding a catalytic amount of activated carbon.
Patent NZ-233493-A (NZ)
Title: Corrosion inhibitors containing alkoxybenzotriazoles
Inventor: VANDERPOOL DANIEL P
IPC: C23F11/14
Filed: 1990-04-30
Abstract: The use of alkoxybenzotriazoles to inhibit the corrosion of metallic surfaces in contact with an aqueous system. Systems and compositions containing alkoxybenzotriazole are also claimed.
Patent NZ-326352-A (NZ)
Title: Hydroxamic acid based collagenase inhibitors useful in the treatment of and prophylaxis of disorders in which the overproduction of soluble CD23 is implicated
Inventor: BAILEY STUART
IPC: A61P25/28
Filed: 1997-01-14
Abstract: Compounds of described formula wherein R and R3 are each independently hydrogen, alkyl, alkenyl, alkynyl or aryl; R1 is arylmethyl; and R2 is alkyl, alkenyl, aryl, cycloalkyl or cycloalkenyl, and pharmaceutically acceptable derivatives thereof, are useful in the treatment and prophylaxis of disorders associated with excess production of soluble CD23 (s-CD23) such as autoimmune disease and allergy is implicated. Human CD23 exists as two differentially regulated isoforms, a and b, which differ only in the amino acids at the intracellular N-terminus. In humans, the constitutive a is only found on B-lymphocytes, whereas type b , inducible by IL-4, is found on all cells capable of expressing CD23. Because of the various properties of CD23, compounds that inhibit the formation of soluble CD23 should have twofold actions a)enhancing negative feedback inhibition of IgE synthesis by maintaining levels of intact, cell bound CD23 (i-CD23), on the surface of the B cells, and b)inhibiting the immunostimulatory cytokine activities of higher molecular weight soluble fragments. In addition, inhibition of CD23 cleavage should mitigate sCD23-induced monocyte activation and mediator activation and mediator formation, thereby reducing inflammatory response.
Patent NZ-331798-A (NZ)
Title: Stormwater sediment and litter trap
Inventor: NICHOLAS DOUGLAS IAN
IPC: E03F1/00
Filed: 1997-02-21
Abstract: A pollution control device (10) for removal of litter and sediments from a flowing stream of stormwater or the like, the device including an upwardly inclined flume (11,18) adapted to be disposed adjacent the discharge end of a stormwater outlet (16) with a collection container (12) at the opposite end of the flume, the flume (18) and the container (12) being fabricated from expanded metal mesh screen. During stormwater flow, litter entrained with the stormwater is urged up the inclined path of the flume (18) for collection in the container (12) whereas sediments are screened from the flume (18) and the container (12) through apertures in the expanded metal screen and pass through to a sediment sump (29) disposed beneath the device (10). Stormwater which has been so screened is then permitted to flow further downstream. A method of separating litter and sediments from a flowing stream of stormwater is also claimed.
Patent NZ-332832-A (NZ)
Title: A process for preparing biconvex rapidly disintegrating dosage forms
Inventor: LAWRENCE JANICE
IPC: A61K9/20
Filed: 1997-06-10
Abstract: Preparation of solid rapidly disintegrating dosage form (SDF) comprising a porous network of matrix forming materials (MFM) comprises: (a) overfilling a mould with a predetermined amount of aqueous composition comprising MFM so that a convex meniscus is created on top of the mould; (b) freezing; and (c) removing the solvent by subjecting the product to lyophilisation or to solid state dissolution leaving a porous network of MFM. The shape of the bottom surface of the mould is a mirror image of the shape of the frozen meniscus on the top, the mirror plane being parallel to the plane defined by the rim of the mould, yielding a dosage form shaped as a biconvex tablet, having symmetrical top and bottom surfaces. The SDF prepared as above is claimed per se. Also claimed is a metal or plastic sheet for use in the above process for preparing dosage forms shaped as biconvex tablets having symmetrical top and bottom surfaces comprising moulds arranged in a regular pattern, the shape of the bottom surface of each mould being a mirror image of the shape of a predetermined convex meniscus on the top, the mirror plane being parallel to the plane defined by the rim of the mould.
Patent NZ-333808-A (NZ)
Title: Process and composition for the antiparasitic treatment of the surroundings of animals by treating their litter with 1-arylpyrazole insecticides
Inventor: JEANNIN PHILIPPE
IPC: C05G3/60
Filed: 1997-07-17
Abstract: The specification describes the control of darkling beetles by insecticides of 1-arylpyrazole type. The composition  can be applied to animal litter, especially for animal rearing.
Patent NZ-335306-A (NZ)
Title: The use of progesterone for treating or reducing ischemia
Inventor: LEVINE HOWARD L
IPC: A61K31/565
Filed: 1997-11-04
Abstract: The use of progesterone in the manufacture of a medicament for treating or reducing ischemia or incidence of cardiovascular. Progesterone, unlike synthetic progestins, has been demonstrated to supplement, rather than to decrease, the beneficial effects of estrogen therapy on myocardial ischemia in females.
Patent NZ-503974-A (NZ)
Title: A composition for controlling dental caries where an enzyme (alpha-glucosidase) that degrades bacterial components is attached to an anchor molecule to prolong the degradative effects
Inventor: BUDNY JOHN A
IPC: A61K47/48
Filed: 1998-10-13
Abstract: A composition for controlling bacterial growth/colonisation is provided. The composition comprises an enzyme, an anchor molecule coupled to the enzyme to form an enzyme-anchor complex, with the anchor being capable of attaching to a substrate proximal to a bacterial colony. The attachment to the substrate permits prolonged retention time of the enzyme-anchor complex where the bacterial colony is present to increase the effectiveness of the complex. The polysaccharide degrading enzymes are derivatised or coupled to the anchor molecules so that they are able to absorb to surfaces and structures in the oral cavity, and inhibit the proliferative bacterial colonisation associated with the plague matrix.
Patent NZ-504114-A (NZ)
Title: Vitamin k-dependent polypeptides such as protein C where substitution at amino acid sites 11, 12, 29, 33 or 34 affects membrane binding affinity of the protein and ultimately blood clotting ability
Inventor: NELSESTUEN GARY L
IPC: C12N15/55
Filed: 1998-10-20
Abstract: A vitamin K-dependent polypeptide comprises a modified GLA domain that comprises a least one amino acid substitution at residues 11,12,29, or 34. The modified GLA domain enhances membrane binding affinity. The polypeptide may further include an amino acid substitution at amino acid 33. The isolated nucleic acid encoding the polypeptide is also described. A protein C or activated protein C can comprise a modified GKA domain. Also described is a pharmaceutical composition comprising a polypeptide with the modified GLA domain, whereby it is suitable for use to modulate clot formation in a mammal.
Patent NZ-505185-A (NZ)
Title: Air freshener taper candle product containing an air freshener component bound to a particulate cellulosic filler
Inventor: ADAMS MARY BETH
IPC: A61L9/02
Filed: 1998-12-17
Abstract: An air freshener candle product, which is a taper-shaped combustible body, comprises: (a) 45-85 wt% of candle wax ingredient; (b) 10-35 wt% of thermoplastic polymer ingredient; and (c) 0.1-20 wt% of particulate cellulosic filler ingredient having air freshener chemically bound to the cellulosic filler; wherein the air freshener constituent is released into the atmosphere under candle burning conditions.
Patent NZ-506260-A (NZ)
Title: Indole-3-propionic acids, salts and esters thereof used as medicaments
Inventor: PAPPOLLA MIGUEL A
IPC: A61P25/28
Filed: 1999-02-23
Abstract: Use of an indole-3-propionic acid or a salt or ester thereof, in the manufacture of a medicament for preventing a cytotoxic effect of amyloid beta protein on cells in a patient in need thereof.
Patent NZ-507762-A (NZ)
Title: Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors
Inventor: RUBIN PAUL D
IPC: A61K31/445
Filed: 1999-04-13
Abstract: Disclosed are methods and pharmaceutical  compositions comprising  both a terfenadine metabolite and a  leukotriene inhibitor,  and optionally a decongestant for the  treatment or  prevention  of inflammation or allergic disorders,  such as  asthma,  dermatitis  and  allergic  rhinitis.   Suitable terfenadine  metabolites include racemic  fexofenadine,  and the  leukotriene inhibitor is selected from a 5-lipoxygenase inhibitor,  a  5-lipoxygenase activating protein  antagonist or a leukotriene receptor antagonist.
Patent NZ-508832-A (NZ)
Title: Artificial ventilation method
Inventor: FUKUNAGA BLANCA M
IPC: A61M16/00
Filed: 1997-10-30
Abstract: Described is an aspect of an artificial ventilation system for administering and exhausting gases to a mammal. The assembly comprises a respiratory conduit and a proximal terminal, wherein the distal end of the conduit is connectable to and detachable from the proximal terminal. The proximal terminal is comprised of a coaxial tube device in which the inner and outer tubes are attachable to the conduit simultaneously. The proximal terminal is shown in FIG. 1, in which there are four ports, an inspiratory port 62, an expiratory port 64, a first respiratory port 66 and a second respiratory port 68, to facilitate independent connections to a source of inspiratory gas and a expiratory outlet. The respiratory conduit is shown as FIG. 2, comprised of a coaxial tube device in which the inner pipe 134 and outer pipe 136 are attachable to the second respiratory port 68 and first respiratory port 66 of the proximal terminal, or connection to a filter device.
Patent NZ-510174-A (NZ)
Title: Overvoltage protection device including wafer of varistor material
Inventor: BALLANCE ROBERT MICHAEL
IPC: H01C7/10
Filed: 1999-09-20
Abstract: An overvoltage protection device includes a first electrode member having a first substantially planar contact surface and a second electrode member having a second substantially planar contact surface facing the first contact surface. A wafer formed of varistor material and having first and second opposed, substantially planar wafer surfaces is positioned between the first and second contact surfaces with the first and second wafer surfaces engaging the first and second contact surfaces, respectively. The contact surfaces may apply a load to the wafer surfaces. Preferably, the electrode members have a combined thermal mass which is substantially greater than a thermal mass of the wafer. The wafer may be formed by slicing a rod of varistor material. The device may include a housing including the first substantially planar contact surface and a sidewall, the housing defining a cavity within which the second electrode is disposed.
Patent NZ-516876-A (NZ)
Title: A method of producing an oil extract from the seeds of the plants meadowfoam, brassicas and crambe and its use in skin conditions e.g. eczema, psoriasis and burns
Inventor: BATHURST CHRISTOPHER FRANCIS
IPC: A23L1/00
Filed: 2002-01-28
Abstract: A method of producing an oil extract from seeds of plants selected from the group including meadowfoam, brassicas and crambe comprises washing the seed with a solvent, preferably the solvent is hexane or a binary azeotropic mixture of hexane and ethanol, whereby oil from the seed is dissolved in the solvent, then separating the spent seed and the solvent solution and distilling the solvent solution at a temperature of equal to or less than 120oC and a pressure equal to or less than 50 kPa to obtain an oil extract from the solvent. The oil extract produced contains a therapeutically effective amount of glucosinolates (GSL) compounds. The extract may contain isothiocyanante (ITCL) and thiocyanate (TCL) or nitrile thiones and phenolic compounds. The oil extract can be mixed with a base aqueous solution to produce a therapeutic aqueous solution. A method for producing a light oil fraction using the oil extract obtained and an oil solution are described. The oil extract, light oil fraction, therapeutic aqueous solution, oil solution or combinations thereof can be used in the production of pharmaceuticals compositions fro the treat of a skin condition and their symptoms selected from eczema, facial eczema, dermatitis, external ulcers, welts, rashes, insect bites, allergic reactions and other irritations, burns, wounds, psoriasis, acneiform eruptions, dryness, dry skin, irritation, skin atrophy and secondary infections. A medicament including a therapeutic amount of GSL and may further contain ITCL and TCL can also be used in the same treatment. Also described is a solid composition comprising the spent seed obtained from the production of the oil extract. The spent seed can be used as a fungicide, anti-mould composition and a food preservative, particularly for fruits, nuts and nut type fruits.